跳至主要内容
临床试验/NCT04191655
NCT04191655已完成不适用

High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 211 人开始时间: 2019年4月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
211
试验地点
2
主要终点
Detection rate of dysplastic lesions in High Definition White Light Colonoscopy versus Dye Spraying Chromo-colonoscopy

研究概览

简要总结

Inflammatory Bowel Disease (IBD) involving the colon is a known risk for colon cancer. There are two standards-of-care colonoscopy techniques used for screening all patients who suffer from IBD for more than eight years. One method is to obtain random biopsies throughout the colon and the other is by using dye spraying chromo-colonoscopy.

This trial aims to study the difference between the two colonoscopy techniques during the era of high definition camera in detecting neoplastic lesions during screening patients with long-standing IBD.

详细描述

Research Question:

Is High Definition White Light Colonoscopy (HDWLC) not inferior to Dye Spraying Chromo-colonoscopy (DSC) in detecting all neoplastic lesions during screening patients with colonic IBD for more than eight years?

Study setting: The study will be conducted at Beth Israel Deaconess Medical Center. Patients will be randomized to HDWLC with biopsies every 10 cm versus DSC.

Study population: Adult patients colonic IBD for more than eight years.

Recruitment The study team will conduct a day by day chart review for all patients with a history of inflammatory bowel disease who were scheduled for screening colonoscopy and find candidates who meet the eligibility criteria. A study team member will meet with the potential candidates during their visit to the gastroenterology procedure room before having their colonoscopy and offer them to participate in the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

In this study, we will randomize a total of 500 participants into two arms: A. high definition white light colonoscopy with biopsy (n=250) or B. chromocolonoscopy (n=250).

The randomization schedule was created by using GraphPad website. Then sealed opaque envelopes which numbered from 1 to 500 for all subjects were created based on the randomization schedules by one of the study co-investigators (Mohammed El-Dallal MD). These envelopes will be opened only by the endoscopy provider once the subject agrees and sings the informed consent. Of note, the randomization schedules will be saved in a separate document that only Mohammed El-Dallal MD has access to it. Neither the participants nor the study members (other than Mohammed El-Dallal MD) know about the assignment before opening the envelopes.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient age ≥18yr old
  • History of UC or colonic Crohn's disease or unclassified colitis patients with or without colonic adenoma history
  • Duration of ≥ eight years since diagnosis, or any duration with a diagnosis of primary sclerosing cholangitis
  • Mucosal lesion involves ≥ 1/3 of the colon

排除标准

  • History of colorectal cancer
  • History of total colectomy
  • Prior colonoscopy within the last 6 months
  • Allergy to dye spray
  • Poor bowel preparation
  • Unable to provide informed consent
  • Severe inflammation preventing visualization of the mucosa during the procedure.

研究组 & 干预措施

High Definition White Light Colonoscopy

Experimental

干预措施: High Definition Colonoscopy (Device)

Dye Spraying Chromo-colonoscopy

Active Comparator

干预措施: Dye Spraying Chromocolonoscopy (Device)

结局指标

主要结局

Detection rate of dysplastic lesions in High Definition White Light Colonoscopy versus Dye Spraying Chromo-colonoscopy

时间窗: Immediately after the procedure

次要结局

  • Numbers of detected adenomas per patient.(Immediately after the procedure)
  • Appropriateness of reported follow up recommendations per standard guideline recommendations(Immediately after the procedure)
  • Detection rate of high-grade dysplasia in both groups.(Immediately after the procedure)
  • Difference in adverse event, mild (e.g.; nausea, vomiting, or abdominal pain that necessitate phone call from the patient to the provider, or sever (e.g.; GI bleeding, perforation, hospitalization after the procedure) for each arm.(Within one week from the procedure date)
  • Number of targeted chromoendoscopies(Immediately after the procedure)
  • Detection rate of Adenoma in both groups.(Immediately after the procedure)
  • Difference in withdrawal time to perform the procedure in both groups.(Immediately after the procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph Feuerstein

Assistant Professor of Medicine

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验

High Definition Colonoscopy (HDC) vs. Dye Spraying... | 临床试验